Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...

Every patient enrolled in a groundbreaking rectal cancer trial has remained disease-free for more than three years after ...

Explore 25 Historic Mysteries Scientists Are Still Unraveling, from vanished cities to lost treasures. Dive into ancient ...

This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...

RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the independent presentation of new preclinical data at the 2026 American Association for ...

A very interesting review in New Scientist makes the point that fungi were not for ancient humans the marginal resources that their near invisibility in the traditional archaeological record might ...

In a new study, scientists analyzed one such strategy used by the bacterium Escherichia coli. One of the enzymes in the ...

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

Scientists have just discovered an entirely new way that DNA can be synthesized. The business of constructing DNA ...

New analytical methods developed at Baylor College of Medicine and collaborating institutions have increased our ...

A new study finds that bacteria can actively block the transfer of beneficial genes to neighboring cells, using specialized ...

Cyanobacteria—ancient microbes that oxygenated Earth and made complex life possible—are still revealing surprises billions of ...